Free Research Report Download:
The Cancer Market Outlook To 2014
Free Pharmaceutical Market Research Reports
Biotechnology
Corporate & Fiscal
Drug Delivery
Health Products
Hospital Markets
Indication Areas
Medical Devices
Prescription Medicines
R&D
Custom Research
Pharmaceutical Events & Conferences
Contact
Terms & Conditions
Privacy
Lyophilisation for Pharmaceuticals: Technology and Market 2010-2025
Market Study
Published: June 2010
Pages: 121
Tables: 42
From: GBP 1499.00 Buy Now!
Research from: Visiongain
Sector: Biotechnology
how will rising demand and technological developments create opportunities?
Lyophilisation (also known as freeze drying or cryodesiccation) is an operation used for the preparation of stable pharmaceutical products. The market for lyophilisation has enjoyed strong growth in recent years, driven by new products and drug classes, especially in biotechnology. In recent years, the number of such products has been growing steadily. It is predicted that half of the injectable drugs approved in the next five years will require lyophilisation. In our new report, we predict that the global lyophilisation market will grow steadily in revenue and unit sales from 2010 to 2025.
Lyophilisation for Pharmaceuticals: Technology and Market 2010-2025 shows how the sector will be driven by the introduction of new products, particularly monoclonal antibodies (MAbs) and other proteins. There will also be developments in drying and packaging technologies. Products benefiting from lyophilisation technology include:
• Active pharmaceutical ingredients (API)
• Vaccines
• Diagnostic kits
• Reagents
• Proteins
• Hormones
• Viral preparations
• Bacterial preparations
• Tissue preparations
• Blood plasma products
• Enzymes
• Pathological samples
• Nutraceuticals
• Vitamins
• Herbal extracts.
There is an increased demand from pharmaceutical companies for manufacturing equipment and services for lyophilisation. As a result, the lyophilisation sector is one of the fastest growing in the global healthcare industry. All the therapeutic segments using lyophilisation have been expanding, but which will grow fastest in years to come? What are the main therapeutic and commercial trends to watch? How will the worldwide market for freeze-drying technology and services perform from 2010 to 2025? Our new report answers questions such as those, providing the information that you need.
Our report shows how the lyophilisation market will experience strong revenue growth from 2010 to 2025, with greater demand for injectable drugs and vaccines requiring drying technologies. There are under-met needs for improved stability and cost effectiveness, as well as for more convenience in transport, storage and use of therapeutic agents. Rapid stabilisation, long-term product stability, ease of reconstitution and process advantages for heat-sensitive products will drive growth of the lyophilisation technology and services market. From 2010 onwards, there will be developments in freeze-drying technology that will benefit the sector and its customers, extending performance and applications.
Detailed analysis of the lyophilisation industry and market
Lyophilisation for Pharmaceuticals: Technology and Market 2010-2025 examines that sector through a comprehensive review of information sources, primary and secondary. This report provides our sales forecasts, market share analyses, discussions of technological developments and analyses of commercial drivers and restraints, including SWOT analysis. There are over 70 tables and figures included and an interview with an industry expert. The result is a comprehensive market- and industry-centred study, with detailed analyses and informed opinion to benefit your work.
Why you should buy Lyophilisation for Pharmaceuticals: Technology and Market 2010-2025
This report gives you the following benefits in particular:
• You will receive a comprehensive analysis of the prospects for lyophilisation products and services, including predicted revenues and other data, by overall market and main subgroup/application
• You will find out how the lyophilisation industry and market will change from 2010 to 2025, with sales forecasts for the global market and leading national markets (US, Japan, UK, Germany, France, Spain, Italy, China and India)
• You will discover the prospects for relevant therapeutic classes, with forecasts and other data for 2010 to 2025
• You will discover how the lyophilisation products and services sector is evolving to deliver improved ease of use, safety, product stability and convenience of transport/storage
• You will analyse the drivers, restraints, competition and opportunities influencing the lyophilisation product and service industries and markets
• You will receive expert views from our survey, including an interview transcript
• You will investigate developments in that sector – technological and commercial – with the most exciting trends and opportunities highlighted.
You can obtain this report today
Nobody with an interest in drug packaging, drug delivery and pharmaceutical biotechnology should overlook our new study. Success from 2010 onwards will be characterised by greater product stability and more-convenient presentation of high-value pharmaceuticals, with the lyophilisation sector benefiting. Rising healthcare demands – coupled with benefits to pharma stakeholders – are drivers of this market. Do you want to harness those opportunities? You can stay ahead by ordering this report today.
Companies Listed
AAIPharma Services
ABC Laboratories
Allergan
Almac
Althea Technologies
Azopharma Product Development Group
Baxter Healthcare
B. Braun Melsungen
Ben Venue Laboratories
Bilcare Global Clinical Supplies, Americas
Biopharma Process Systems
Biopharma Technology
Cangene Biopharma
Catalent Pharma Solutions
CMC Biologics
Coldstream Laboratories
DSM Pharmaceuticals
European Medicines Agency (EMEA)
Food and Drug Administration (US FDA)
Formatech
Freezedry Specialties
Fresenius Kabi Product Partnering
FTS Systems
Galenix
GEA Lyophil (GEA Pharma Systems, GEA Group)
Genentech
Girindus America
Gland Pharma
GP Pharm
Grand River Aseptic Pharmaceutical Packaging
Haemtech Biopharma Services
Haupt Pharma
HollisterStier Contract Manufacturing
Hospira One 2 One
Hovione
Huapont Pharm. Co.
Hyaluron Contract Manufacturing (HCM)
IDT Biologika
IMA Edwards Pharmaceutical Systems
Impact Analytical
Intas Biopharmaceuticals
Irvine Pharmaceutical Services
JHP Pharmaceuticals
Jouan Nordic
KBI Biopharma
King Pharmaceuticals
KP Pharmaceutical Technology
Lab. PiSA
Labconco Corporation
Lampire Biological Laboratories
Legacy Pharmaceuticals International
Lonza
Lyophilisation Services of New England (LSNE)
Lyophilisation Technology
Martin Christ Gefriertrocknungsanlagen
MedPharm
Miltenyi Biotec, Bioprocess Division
Ministry of Health, Labour and Welfare (Japan)
Molecular Profiles
National Archives and Records Administration (NARA), Document Conservation Laboratory (DCL)
Nextar Chempharma Solutions (formerly Aminolab Pharma)
NextPharma
Nicholas Piramal
Niro
Nycomed
Oakwood Laboratories
OctoPlus
Om Bhagwati Labelling Technologies
Omnia Biologics
One 2 One Global Pharmaceutical Services (Hospira)
Optima Machinery Corporation
Oregon Freeze Dry
Oso BioPharmaceutical Manufacturing
Overlook Industries
Patheon
Pfizer CentreSource
Pharmatek Laboratories
Piramal Healthcare
PolyPeptide Laboratories
Quality Assistance
Rana Diagnostics
Reig Jofré Group
RFCL
Richman Chemical
Roche
SAFC Pharma
Sandoz (part of Novartis)
Scripps Laboratories
Serail Freeze-Drying Systems
SL Pharma Labs
Solvay
SP Formulations
SP Industries
SRI International
Stason Pharmaceuticals.
Therapure Biopharma
Thermo Fisher Scientific
University of Iowa Pharmaceuticals (UIP)
USIFROID
Vectech
Vetter Pharma International
Vetter Pharma-Fertigung
Walter Reed Pilot Bioproduction Facility